GLP-1 usage reaches 11% of US adults, shifting grocery and snack spend
Question
GLP-1 usage reaches 11% of US adults, shifting grocery and snack spend
Direct answer
Adoption of GLP-1 receptor agonists has reached 11% of the adult US population, generating continued top-line acceleration for drug manufacturers Eli Lilly and Novo Nordisk. The expanded user base is driving measurable shifts in grocery basket composition. Packaged food, snack, and beverage giants including PepsiCo, Hershey, and Mondelez face volume growth constraints as consumers curb discretionary calorie and snack purchases, challenging historical pricing power dynamics. — bearish pressure on PEP.
- Original publisher
- Market Ontology
- Evidence through
- 2026-10-12
- Published
- 2026-10-20
- Revision
- 1 · 2026-10-20
Cite as: Market Ontology, “GLP-1 usage reaches 11% of US adults, shifting grocery and snack spend”, revision 1, evidence through 2026-10-12. https://marketontology.com/catalysts/2026-10-12/glp-1-usage-reaches-11-of-us-adults-shifting-grocery-and-snack-spend-2a3c42
| Asset | Direction | Timeframe | Channel | Score |
|---|---|---|---|---|
| PEP | ▼Bear | 1–3 months | Macro Repricing | 72 |
| MDLZ | ▼Bear | 1–3 months | Macro Repricing | 71 |
GLP-1 usage reaches 11% of US adults, shifting grocery and snack spend
Adoption of GLP-1 receptor agonists has reached 11% of the adult US population, generating continued top-line acceleration for drug manufacturers Eli Lilly and Novo Nordisk. The expanded user base is driving measurable shifts in grocery basket composition. Packaged food, snack, and beverage giants including PepsiCo, Hershey, and Mondelez face volume growth constraints as consumers curb discretionary calorie and snack purchases, challenging historical pricing power dynamics. — bearish pressure on PEP.
Adoption of GLP-1 receptor agonists has reached 11% of the adult US population, generating continued top-line acceleration for drug manufacturers Eli Lilly and Novo Nordisk. The expanded user base is driving measurable shifts in grocery basket composition. Packaged food, snack, and beverage giants including PepsiCo, Hershey, and Mondelez face volume growth constraints as consumers curb discretionary calorie and snack purchases, challenging historical pricing power dynamics.
- SummaryAdoption of GLP-1 receptor agonists has reached 11% of the adult US population, generating continued top-line acceleration for drug manufacturers Eli Lilly and Novo Nordisk. The expanded user base is driving measurable shifts in grocery basket composition. Packaged food, snack, and beverage giants including PepsiCo, Hershey, and Mondelez face volume growth constraints as consumers curb discretionary calorie and snack purchases, challenging historical pricing power dynamics.
- PEPDirect directional or hedged short
Illustrative, not advice
- Crowded positioning may already reflect the move
- Counter-catalyst could neutralize the thesis before window closes
- Fed officials or competing data may reframe the print
- PEP closes above pre-catalyst level on rising volume
- Catalyst narrative is officially walked back or contradicted
- Cross-asset confirmation (rates / FX / vol) reverses direction
- PEP price vs. pre-event level
- PEP volume vs. 20-day average
- 2Y/10Y Treasury yield direction
- DXY direction
- Fed funds futures repricing
GLP-1 usage reaches 11% of US adults, shifting grocery and snack spend
Adoption of GLP-1 receptor agonists has reached 11% of the adult US population, generating continued top-line acceleration for drug manufacturers Eli Lilly and Novo Nordisk. The expanded user base is driving measurable shifts in grocery basket composition. Packaged food, snack, and beverage giants including PepsiCo, Hershey, and Mondelez face volume growth constraints as consumers curb discretionary calorie and snack purchases, challenging historical pricing power dynamics. — bearish pressure on MDLZ.
Adoption of GLP-1 receptor agonists has reached 11% of the adult US population, generating continued top-line acceleration for drug manufacturers Eli Lilly and Novo Nordisk. The expanded user base is driving measurable shifts in grocery basket composition. Packaged food, snack, and beverage giants including PepsiCo, Hershey, and Mondelez face volume growth constraints as consumers curb discretionary calorie and snack purchases, challenging historical pricing power dynamics.
- SummaryAdoption of GLP-1 receptor agonists has reached 11% of the adult US population, generating continued top-line acceleration for drug manufacturers Eli Lilly and Novo Nordisk. The expanded user base is driving measurable shifts in grocery basket composition. Packaged food, snack, and beverage giants including PepsiCo, Hershey, and Mondelez face volume growth constraints as consumers curb discretionary calorie and snack purchases, challenging historical pricing power dynamics.
- MDLZDirect directional or hedged short
Illustrative, not advice
- Crowded positioning may already reflect the move
- Counter-catalyst could neutralize the thesis before window closes
- Fed officials or competing data may reframe the print
- MDLZ closes above pre-catalyst level on rising volume
- Catalyst narrative is officially walked back or contradicted
- Cross-asset confirmation (rates / FX / vol) reverses direction
- MDLZ price vs. pre-event level
- MDLZ volume vs. 20-day average
- 2Y/10Y Treasury yield direction
- DXY direction
- Fed funds futures repricing
What happened next
| Asset | Call | Base close | +1 day | +5 days | +20 days |
|---|---|---|---|---|---|
| PEP | Bearishdisagreed | 126.68 2026-10-12 | +0.49% | Pending | Pending |
Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.
No verifiable public source recorded for this card.
Related catalysts
- 2026-10-12GLP-1 Adoption Reaches 11% of US Adults, Pressuring Packaged Food SpendLLY MDLZ PEP+0.49%
- 2026-10-12GLP-1 Penetration Reaches 11% of US Adults, Pressuring Packaged Snack and Beverage VolumesLLY PEP+0.49%
- 2026-10-12GLP-1 usage reaches 11% of US adults, shifting grocery and snack spendLLY MDLZ NVO PEP+0.49%
- 2026-10-12GLP-1 Adoption Reaches 11% of US Adults, Pressuring Packaged Food SpendLLY MDLZ PEP+0.49%
- 2026-10-12GLP-1 usage reaches 11% of US adults, shifting grocery and snack spendLLY MDLZ NVO PEP+0.49%
- 2026-10-12GLP-1 Penetration Reaches 11% of US Adults, Pressuring Packaged Snack and Beverage VolumesLLY PEP+0.49%
- 2026-10-12GLP-1 Penetration Reaches 11% of US Adults, Pressuring Packaged Snack and Beverage VolumesLLY PEP+0.49%
- 2026-10-09PepsiCo cuts FY profit guide despite Q3 EPS beat on North America costs — PEP margin-compression repricingPEP+4.38%
See today's live cards
Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.